CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators
CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative ...
News Medical on MSN1d
Scientists pinpoint metabolic failure as the cause of muscle loss in aging
A multi-omics study reveals that impaired branched-chain amino acid (BCAA) catabolism is a key driver of sarcopenia, ...
Breakthrough could provide a lifeline for ailing British bee population
Declining bee populations could be saved by highly targeted new pesticides which attack parasites without harming other ...
AcrVIB1: The unexpected anti-CRISPR protein that tightens RNA binding
The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to ...
GlobalData on MSN1d
Moderna reports decline in Q4 2024 revenue
Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 - a sharp decline from the $2.8bn recorded in the ...
Bill to ban mRNA vaccines passes out of House committee
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
Curevac Earns Repeat Recognition By Lexisnexis® As One Of The World’S Top Innovators
CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolio The company holds one of ...